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Abstract
Purpose—Informal care plays an important role in the overall care for people with cancer. This 
study estimates lost productivity and informal caregiving and associated costs among partner 
caregivers of localized prostate cancer patients within 1 year after diagnosis.
Methods—We applied data from the Family and Cancer Therapy Selection study, a three-wave 
self-administered survey among patients diagnosed with localized prostate cancer and their partner 
caregivers in multiple clinics in the USA. Time spent was measured by the sum of working hours 
lost, informal caregiving hours performed, and hours spent on household chores. The national 
median income for women 55 years or older was used to calculate costs associated with the time 
spent using the opportunity cost method. Descriptive and bivariate analyses were conducted.
Results—The average working hours decreased from 14.0 h/week (SD=17.6) to 10.9 h/week 
(SD=15.9), without a significant change in responsibility/intensity at work. The mean annual time 
spent on informal caregiving and household chores was 65.9 h/year (SD=172.4) and 76.2 h/year 
(SD=193.3), respectively. The mean annual economic burden among partner caregivers was US
$6,063 (range US$571–US$47,105) in 2009 dollars accounted for by a mean of 276.2 h (range 
26–2,146) in the study sample. The time spent on informal caregiving and household chores 
varied by patient and caregiver characteristics.
Conclusions—Pilot estimates on non-medical economic burden among partner caregivers 
(spouses) during the initial phase of the treatment provide important information for 
comprehensive estimation of disease burden and can be used in cost-effectiveness analyses of 
prostate cancer interventions.
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Introduction
Informal care plays an important role in the overall care for people with chronic and 
terminal diseases. It is increasingly being considered as a valuable substitute for formal care 
and presents large national economic value [1, 2]. The demand for informal care is expected 
to increase in the future due to the aging of the population and, therefore, becomes a 
growing public health issue.
Cancer caregiving is generally viewed as one of the most stress-inducing caregiving 
challenges faced by family members [3], which typically requires intensive involvement of 
family caregivers to help administer complex medical regimens (e.g., pain management) in 
addition to providing assistance with daily activities. Additionally, the demand for informal 
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care varies greatly by patient stage at diagnosis and phase of treatment [2, 4]. Patients newly 
diagnosed or with recent cancer treatment were more likely to receive informal caregiving 
compared to those without cancer or recent cancer treatment [5, 6]. Most prior economic 
studies focused on treatment costs and productivity lost among patients [7–10]. For 
caregivers, more attention has been paid on the effect of caregivers' opportunity costs and 
quality of life [2, 11–14]. Economic burden among caregivers varied by patient's medical 
and caregiver's sociodemographic characteristics [2, 12]. Economic burden among 
caregivers of prostate cancer patients has been rarely studied, however.
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of 
cancer-related deaths among men in the USA [15]. Prostate cancer primarily affects men 50 
years of age and older and disproportionately affects men of African American descent [15]. 
There were approximately 2.3 million men with a history of prostate cancer in 2007, and 
80% were diagnosed at localized stage [16, 17]. The number of men with prostate cancer is 
expected to increase in future years because of the higher incidence among the elderly, 
increasing life expectancy, and growth of the aging US population [18]. All treatment 
options for prostate cancer result in adverse effects (primarily urinary, bowel, and sexual), 
which may affect the daily activities and quality of life of both patients and caregivers [19–
21]. Spouses of patients with prostate cancer play a major role in helping men manage the 
illness and need to be included in programs of care [21].
The purpose of this study is to estimate costs associated with lost productivity and informal 
caregiving among partner caregivers of localized prostate cancer patients within 1 year after 
diagnosis and to examine the variation in such burden by patient and partner caregiver's 
characteristics. To our knowledge, no studies have reported costs associated with informal 
caregiver time during the initial phase of treatment among prostate cancer patients 
diagnosed with localized disease. Such information is important to fully assess the disease 
burden and estimate the cost-effectiveness of prostate cancer control intervention and 
framing issues for interventions targeting family caregivers of localized prostate cancer 
patients.
Methods
Study design
We conducted a retrospective analysis using data from the Family and Cancer Therapy 
Selection study, a three-wave self-administered survey among patients newly diagnosed 
with localized prostate cancer and family caregivers in multiple clinics in the USA. 
Recruitment procedures and patient eligibility are described elsewhere [22]. Briefly, 423 
newly diagnosed patients were approached in urology practice sites in California, South 
Carolina, and Texas. Eligible patients (n=240) included those diagnosed with incident 
localized prostate cancer, who had not initiated treatment other than hormone therapy at the 
time of approach. Interested patients signed consent forms and received a take-home survey 
to return by mail. Patients identified a family caregiver to participate in a separate baseline 
survey. Mailed follow-up surveys to patients and family caregivers were administered at 6 
and 12 months; however, questions on employment status and time spent by caregivers were 
asked at 12-month follow-up only. Study materials were approved by the institutional 
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review board at each accrual site and the coordinating center. Participants received US$25 
for completing the baseline survey.
One hundred ninety-three family caregivers of the 240 eligible patients participated in the 
baseline survey, and 96 completed the 12-month survey. We restricted our analyzed sample 
to the 88 spouses/partners who completed the 12-month survey and lived in the same 
household with patients because annual household income was only collected among 
patients (Fig. 1).
Measures
Economic burden—At 12-month follow-up, the partner caregivers were asked about 
their change in employment status, change in working hours per week, and change in work 
responsibility/intensity due to prostate cancer care compared with their status 12 months 
ago. The partner caregivers were also asked about their time (hours per week) spent on 
informal caregiving (e.g., going to the doctor with the patient or helping with his health 
care) and time spent on household chores previously done by patients (e.g., mowing the 
lawn, cooking and cleaning, household repair, managing household finances, and other 
activities) in the past 4 weeks. The responses to each question about time were ordinal 
categorical groups (none or less than 1, 1–2, 3–5, 6–10, 11–19, and ≥20 h/week), and the 
midpoint of each group was used as the value of time spent by each respondent on that type 
of activity (household chores, informal caregiving, and working hours). The total annual 
time spent on working hours, informal caregiving hours, and household chore hours (i.e., 
work hours lost/week×36+informal caregiving hours/week×52+household chore hours/
week×52) was calculated. The annual economic burden associated with the time spent was 
measured by multiplying the total annual time spent with the annual national median income 
for women 55 years or older using the opportunity cost method (i.e., the cost of an 
alternative that must be forgone in order to pursue a certain action). All costs were in 2009 
dollars.
Patient characteristics—Patient sociodemographic characteristics included age (<65, 
65+years), race/ethnicity (non-Hispanic white, non-Hispanic black/Hispanic/Asian), 
education (some college or less vs. college graduate or higher), employment status (yes/no), 
annual household income (<US$40,000, US$40,000–US$74,999, US$75,000+), and 
insurance status (Medicare, non-Medicare private insurance, military insurance, other/
unknown), and whether “time away from work” was an important factor in the treatment 
choice (yes/no). Patient health status included disease classification (moderate/high-risk 
group vs. low-risk group) [23], self-reported health status (excellent, very good, good, fair, 
and poor), number of comorbidities (0, 1, 2+), the SF-12 Mental and Physical Component 
Summary Scale [24], and patient function after prostate cancer treatment measured by the 
Expanded Prostate Cancer Index Composite score [25] (a proxy for severity of side effects; 
urinary, bowel, and sexual scores ranged from 0–100, with 100 reflecting the best symptom 
status).
Caregiver characteristics—Caregiver sociodemographic characteristics included age, 
race/ethnicity, education, employment status, annual household income, and whether “time 
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away from work” was an important factor in treatment choice (yes/no). Caregiver health 
status was assessed using self-reported health (excellent, very good, good, fair, and poor) 
and the SF-12 Mental and Physical Component Summary Scale.
Statistical analysis
Descriptive and bivariate analyses—We described the sample characteristics for 
patients and partner caregivers. We also compared the analyzed sample with the full study 
sample at baseline to examine potential selection bias. We assessed mean total hours spent 
on workplace hours, informal caregiving, and household chores for the analyzed sample, and 
examined whether time spent differed significantly by patient and caregiver's characteristics 
using F-statistics following a previous publication [2]. A significance level of 0.05 was 
used. Analyses were conducted using Stata 11.2 SE [26].
Sensitivity analysis—We reanalyzed the data using a time value that was the low and 
high end point of each time category. In addition, we calculated the time costs using median 
usual weekly earnings among women who usually worked 10–14 h/week from the Census 
data.
Results
The median age among the 88 partner caregivers included in the analysis was 61.5 years 
(range 34–80), with 21.6 % older than 67 years. The caregivers were predominantly non-
Hispanic whites (78.4 %) with at least a college education (58.0 %). Most families (62.5 %) 
reported an annual household income of US$75,000 or more. Fifty-seven percent of the 
caregivers reported having excellent/very good health. Only 1.2 % of caregivers reported 
that “time away from work” was important in treatment choice compared with 9.4%of 
patients (Table 1). No significant differences in the characteristics of our sample as 
described in Table 1 (e.g., patient age, caregiver age, and household income) were found 
between the analyzed sample (n=88) and the original study sample (n=193) (data not 
shown).
At the start of the study, a little more than two-thirds of the caregivers (39 of 88) were 
engaged in full- or part-time employment (working hours/week>0) compared with 35 of 88 
at 12-month follow-up (Fig. 2). Two of the 49 caregivers who did not work outside the 
home at baseline started working outside the home after the cancer diagnosis (age=63 and 
64, respectively), while 6 out of the 39 caregivers who reported working outside the home at 
baseline dropped out of work (5 out of 6 were 62 years or younger). Among those who 
continued working, 82.4 % reported no change in “work responsibility/intensity”. However, 
mean working hours decreased from 14.0 h/week (SD=17.6) to 10.9 h/week (SD=15.9). The 
mean time spent on informal caregiving was 1.3 h/week (SD=3.3) and 1.5 h/week (SD=3.7) 
on household chores (previously done by patients) (Table 2). Assuming the estimates of 
time spent per week in the past 4 weeks before the 12-month survey was representative of 
the mean time spent across the 12 months following diagnosis, the mean total time spent 
was 276.2 h (range 26–2,146) per year, accounted for by 76.2 h of household chore time, 
65.9 h of informal caregiving, and 134.1 h of lost work productivity in the study sample of 
partner caregivers. The mean total time spent among partner caregivers of localized prostate 
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cancer patients translates into a mean annual economic burden of US$6,063 (range US$571–
US$47,105) (2009 dollars) based on national median wage rate for full-time worker among 
women aged 55 years or older. The economic burden is US$2,530 (range US$242–US
$19,691) based on national median wage rate among women who usually worked 10–14 h/
week. The results from sensitivity analyses and the influence of assumptions about wage 
rates are presented in Table 3.
White caregivers reported to spend more time on informal care than non-white (black, 
Hispanic, or Asian) caregivers. Caregivers reported spending more time on informal care 
among patients with moderate- to high-risk prostate cancer and those who experienced 
moderate to severe side effects on sexual function compared with their counterparts. 
Caregivers with some college education or less reported spending more time on informal 
caregiving and household chores than those who had an education of college graduate or 
higher. Caregivers with annual household income less than US$40,000/year reported 
spending more time on household chores than those who had higher annual household 
income. Among those patients who were employed at the time of diagnosis and those who 
experienced moderate to severe sexual function decline, their caregivers spent more time 
doing household chores that used to be done by patients compared with caregivers of their 
counterparts (Table 4).
Discussion
This study retrospectively estimated economic burden among family caregivers (spouses/
partners) of patients diagnosed with localized prostate cancer within 1 year after diagnosis. 
Notably, caregivers in our sample appeared to have given up approximately 134 annual 
hours of paid employment and experienced increases in the number of hours spent 
performing informal caregiving and household chores. The mean annual economic burden 
of these tradeoffs among the study sample of partner caregivers due to localized prostate 
cancer treatment translates to US$6,063 in 2009 dollars. If our sample was representative of 
the 1.8 million individuals with localized prostate cancer and their spouses/partners in the 
USA, this would translate into an annual cost to society of US$11.0 billion. Time spent on 
informal caregiving and household chores varied by patient and partner caregiver 
characteristics.
The time spent among caregivers estimated in this study was approximately 2.6 times (in 
magnitude) that of patient time associated with cancer care (such as time associated with 
travel to and from care, waiting for appointments, and receiving care) during the initial 
phase of treatment among patients diagnosed with prostate cancer [8]. However, it is not 
feasible to meaningfully compare the estimates of time spent and associated economic 
burden from this study with previous studies on caregiver burden for cancer patients due to 
the differences in study time frame, study sample recruitment strategy, and activities 
included in informal caregiving estimation [2, 5, 12].
Previous research has found that caring for a husband with an advanced illness presents 
challenges to a caregiver's work life including diminished productivity, decreased quality of 
work, and missed opportunities for promotion [27]. Most previous studies examined 
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employment outcome among patients treated for prostate cancer with little attention paid to 
treatment impact on caregiver's employment status [28, 29]. This study identified some 
impact on partner employment; partners experienced both job seeking and early retirement. 
Previous studies found that the probability of dropping out of work increases with the 
caregiver's age and female gender, and significantly decreases with the caregiver's reported 
annual family income [30]. Furthermore, partner caregivers likely arrive at the decision to 
terminate employment or stop working outside the home jointly with the patient; therefore, 
patient's education level, employment status, and insurance coverage should be considered. 
We were not able to observe such a relationship in our study sample partially because of a 
small sample size (low frequency of observed change in employment status), and most of 
the caregivers were women older than 60 years with an annual household income of US
$75,000 or more.
The time spent on informal caregiving and household chores varied significantly by 
caregivers' characteristics. Caregivers with lower SES (e.g., lower education or lower annual 
household income) reported spending more time on informal caregiving and household 
chores than their counterparts. On one hand, this may be due to lower opportunity costs for 
them to spend more time on informal caregiving and household chores, while people with 
higher annual household income may have more resources available to hire someone to help 
with their household chores. On the other hand, caregivers who have low income may 
experience more distress because they may have fewer resources to meet care demands. 
Caregivers also reported spending more time on informal care and household chores among 
patients who experienced moderate to severe side effects on sexual function, which 
suggested that prostate cancer treatment affected daily activities and quality of life among 
partner caregivers.
Some limitations are noteworthy in this study. First, the results estimated in this study may 
not be representative of those in the general population with localized prostate cancer 
because patients and partner caregivers were convenience samples recruited in three study 
clinics. As a result of small sample sizes, study estimates were unstable with large standard 
deviation. Second, we did not have a control group for employed caregivers, so changes in 
employment may not be directly attributable to cancer. In addition, we examined the 
employment outcome of caregivers at 12 month after diagnosis. The greatest reduction in 
patients' labor supply was observed 6 months following diagnosis [29]. Our figures may be 
an underestimate if the effect on caregiver employment follows a similar pattern as observed 
among patients. Similarly, we may underestimate the total annual time spent on informal 
caregiving and lost productivity using data from the past 4 weeks before the 12-month 
follow-up survey [31]. Third, our results of the impact of prostate cancer treatment on 
employment status among family caregivers may be overestimated at the national level 
because the mean age of the caregivers in the study sample was 60.4 years, while the 
national average age at retirement is 62 in the USA which is expected to increase to 67 years 
in 2012. Furthermore, the average age of retirement (stop working) varies by race, income 
bracket, place of residence, and occupation. Fourth, no information is available for other 
components of economic burden of caregivers such as out-of-pocket costs for transportation, 
nondurable supplies, nutritional supplements, and specialized home health equipment. In 
addition, “informal caregiver effect” and “family effect” have been studied for caregivers of 
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patients with chronic conditions. In this study, we only estimated economic burden 
associated with time among caregivers but did not include a comprehensive measure of 
other caregiver burden such as psychological health which might be associated with medical 
care use. Thus, we cannot estimate the total economic burden for partner caregivers of 
localized prostate cancer patients.
Our study is unique in several ways. Our collection of economic burden data is novel and 
captures three important domains—employment, informal caregiving, and household chores
—which were domains identified as important to patients and caregivers in our initial focus 
caregiver groups [22]. Although our sample is small, it reflects the experience of patients in 
three states from diverse clinical settings. Our patient/partner dyads were prospectively 
recruited together at the time of the patient's prostate cancer diagnosis, prior to treatment. 
This is important because we are able to examine differences in economic burden based on 
observed changes in patient's health over the first year of treatment. To the authors' best 
knowledge, this is the first study to examine economic burden of informal caregivers of 
patients diagnosed with localized prostate cancer at the initial phase of treatment (within 12 
months after diagnosis). Such information is important for comprehensive estimation of 
disease burden and can potentially be used in cost-effectiveness analyses of prostate cancer 
(screening) and treatment interventions, as well as to inform interventions targeting family 
caregivers. Furthermore, this information can help guide patients and caregivers when 
considering treatment alternatives including active surveillance and watchful waiting [32].
Conclusion
Increasingly attention has been paid to productivity savings from prevention and control 
strategies [33]. Public health response has been intended to address known aspects of 
caregiver burden in other countries [34]. We hope that, given the suggestion of excess time 
borne by caregivers relative to patients, the results of our study will make researchers, 
clinicians, and policy makers more aware of the burden that cancer treatment places on 
patients' families and motivate them to consider additional support to those patients and 
caregivers in need in the USA. Future studies are needed to further examine family 
caregiver's economic burden associated with prostate cancer treatment in a larger sample 
including family members other than spouses/partners and to explore potential interventions 
to reduce such burden especially among those who are poor or underinsured.
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Fig. 1. 
Consort flow diagram for analyzed sample from the Family and Cancer Therapy Selection 
study (n=88 partner caregivers)
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Fig. 2. 
Distribution of partner's working hours per week at baseline and 12-month surveys
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Table 1
Description of sample characteristics of prostate cancer patients and partner caregiver pairs at baseline
Characteristic Patients Partner caregiver
Total n=88 % n=88 %
Age (years)
  <65 44 50 60 68.2
  65+ 44 50 28 31.8
  Median (range) 65 (47–81) 61.5 (34–80)
Race/ethnicity
  Non-Hispanic white 71 83.5 69 78.4
  Non-Hispanic black/Hispanic/Asian 14 16.5 19 21.6
Insurance
  Medicare 31 36.5 n/a n/a
  Private (non-Medicare) 34 40 n/a n/a
  VA/military 16 18.8 n/a n/a
  Other/unknown 4 4.7 n/a n/a
Employment
  Full time/part time/self-employed 60 68.2 39 44.3
  Retired/unemployed/unknown 28 31.8 49 55.7
Education
  High school or less 7 8 10 11.4
  Some college 19 21.6 27 30.7
  College graduate 30 34.1 36 40.9
  Graduate degree 29 33 15 17.1
Household income (US$/year)
  <40,000 13 14.8 13 14.8
  40,000–74,999 16 18.2 16 18.2
  75,000+ 55 62.5 55 62.5
“Time away from work” was important in treatment choice
  Yes 8 9.4 1 1.2
  No 77 90.6 86 98.8
Disease classification
  Low risk 45 51.1 n/a n/a
  Moderate/high risk 43 48.9 n/a n/a
Number of comorbidities
  0 27 30.7 n/a n/a
  1 37 42.1 n/a n/a
  2+ 24 27.2 n/a n/a
  Median (range) 1 (0–6) n/a n/a
Self-reported health at baseline
  Excellent/very good 57 66.3 50 56.8
  Good/fair/poor 29 33.7 38 43.2
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Characteristic Patients Partner caregiver
Change in EPICa domain summary scores (12-month vs. baseline)
  Urinary irritation function
    No change/increase/mild decrease 74 90.2 n/a n/a
    Moderate/severe decrease 8 9.8 n/a n/a
  Urinary incontinent function
    No change/increase/mild decrease 58 69.9 n/a n/a
    Moderate/severe decrease 25 30.1 n/a n/a
  Sexual
    No change/increase/mild decrease 52 61.9 n/a n/a
    Moderate/severe decrease 32 38.1 n/a n/a
Survey site
  California 57 64.8 57 64.8
  Texas 16 18.2 16 18.2
  South Carolina 16 17.1 16 17.1
SF-12 component summary scales, mean (SD)
  Physical component summary 52.8 8.2 51 10.1
  Mental component summary 50.5 10.3 48 10
n/a not applicable
a
The Expanded Prostate Cancer Index Composite (EPIC) score (Wei et al. 2000)
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Table 2
Occupational and economic impact of prostate cancer treatment on partner caregivers within 1 year after 
diagnosis
Number Percentage
Change in employment status (n=88)
  Remained unemployed/retired 47 53.4
  Remained employed 33 37.5
  Started working 2 2.3
  Dropped out of work 6 6.9
Working hours/week at baseline (mean, SD)a 14 17.6
Working hours/week at 12-month survey (mean, SD) 10.9 15.9
Change in work responsibility/intensity (n=34)
  Less 3 8.8
  The same 28 82.4
  More 3 8.8
  Not applicable
Time on informal caregiving (h/week)
  <1 64 80
  1–2 11 13.8
  3–5 2 2.5
  6–10 0 0
  11–19 1 1.3
  20+ 2 2.5
  Mean (SD) 1.3 3.3
Time on household chores (h/week)b
  <1 72 84.7
  1–2 6 7.1
  3–5 2 2.4
  6–10 2 2.4
  11–19 0 0
  20+ 3 3.5
  Mean (SD) 1.5 3.7
aWorking hours/week was significantly lower at 12-month survey compared with baseline, p=0.004
b
Time on household chores was for activities used to be done by patients before prostate cancer diagnosis
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Table 3
Results for sensitivity analyses
Low bound High bound Middle point
Lost working hours/year 106.4 151.4 134.1
Household chore hours/year 53.9 102.1 76.2
Informal caregiving hours/year 44.0 135.6 65.9
Total hours/year 204.2 389.0 276.2
Value 1 (US$/year)a 4,483 8,539 6,063
value 2 (US$/year)b 1,871 3,563 2,530
aValue 1 was based on annual national median income for women 55 years or older
bValue 2 was based on median usual weekly earnings among women who usually worked 10–14 h/week
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